An outbreak of genomically clustered group A Streptococcus in a school community, Victoria, 2023
DOI:
https://doi.org/10.33321/cdi.2025.49.060Keywords:
disease outbreak, streptococcal infections, invasive group A Streptococcus, Streptococcus pyogenes, scarlet fever, genomic clusterAbstract
In 2023, a global increase in invasive group A streptococcal disease (GAS) caused serious illness and death. The North Eastern Public Health Unit (NEPHU) in Victoria, Australia, identified an outbreak of GAS in a school in July 2023; we investigated to describe the epidemiology, to identify risk factors for severe disease, and to implement control measures. We defined confirmed cases as those with laboratory, clinical and epidemiological evidence. Probable cases had clinical evidence with an epidemiological link to a confirmed case but no laboratory evidence. Absentee data were collated for students preceding the onset of the index case. We developed an online, self-administered survey for all students to identify contacts with clinically compatible illnesses. Cultures were genomically sequenced. We identified 11 cases (five confirmed, six probable) among the cohort of 38 (a 29% attack rate), with onset dates from 24 July to 27 August 2023. The index case had a severe invasive GAS infection requiring hospitalisation; eight of 11 cases (73%) reported sore throat and one reported scarlet fever as their primary syndrome. Fifteen of 28 students (54%) were absent from the school during the period preceding the index case’s onset. We monitored for two incubation periods following the onset of the last case to 5 September 2023 (six days), with no further cases identified. Isolates all typed as emm1, with genomic clustering consistent with localised transmission. This outbreak demonstrated group A Streptococcus (GAS) transmissibility in a school with multiple clinical manifestations.
Downloads
References
Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94. doi: https://doi.org/10.1016/S1473-3099(05)70267-X.
Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A et al. Disease manifestations and pathogenic mechanisms of group A streptococcus. Clin Microbiol Rev. 2014;27(2):264–301. doi: https://doi.org/10.1128/CMR.00101-13.
Steer AC, Lamagni T, Curtis N, Carapetis JR. Invasive group A streptococcal disease: epidemiology, pathogenesis and management. Drugs. 2012;72(9):1213–27. doi: https://doi.org/10.2165/11634180-000000000-00000.
Thomson TN, Campbell PT, Gibney KB. The epidemiology of invasive group A streptococcal disease in Victoria, 2007–2017: an analysis of linked datasets. Aust N Z J Public Health. 2022;46(6):878–83. doi: https://doi.org/10.1111/1753-6405.13290.
O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis. 2007;45(7):853–62. doi: https://doi.org/10.1086/521264.
Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfield R et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005–2012. Clin Infect Dis. 2016;63(4):478–86. doi: https://doi.org/10.1093/cid/ciw248.
Carapetis JR, Jacoby P, Carville K, Ang SJJ, Curtis N, Andrews R. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis. 2014;59(3):358–65. doi: https://doi.org/10.1093/cid/ciu304.
Robinson KA, Rothrock G, Phan Q, Sayler B, Stefonek K, Van Beneden C et al. Risk for severe group A streptococcal disease among patients’ household contacts. Emerg Infect Dis. 2003;9(4):443–7. doi: https://doi.org/10.3201/eid0904.020369.
Mearkle R, Saavedra-Campos M, Lamagni T, Usdin M, Coelho J, Chalker V et al. Household transmission of invasive group A Streptococcus infections in England: a population-based study, 2009, 2011 to 2013. Euro Surveill. 2017;22(19):30532. doi: https://doi.org/10.2807/1560-7917.ES.2017.22.19.30532.
Herrera AL, Huber VC, Chaussee MS. The association between invasive group A streptococcal diseases and viral respiratory tract infections. Front Microbiol. 2016;7:342. doi: https://doi.org/10.3389/fmicb.2016.00342.
Tyrrell GJ, Lovgren M, Kress B, Grimsrud K. Varicella-associated invasive group A streptococcal disease in Alberta, Canada—2000–2002. Clin Infect Dis. 2005;40(7):1055–7. doi: https://doi.org/10.1086/428614.
Goldsmith JJ, Vu C, Zhu Z, MacLachlan JH, Thomson TN, Campbell PT et al. The associations between invasive group A streptococcal disease and infection with influenza, varicella, or hepatitis C viruses: a data linkage study, Victoria, Australia. Int J Infect Dis. 2024;141:106969. doi: https://doi.org/10.1016/j.ijid.2024.02.012.
Guy R, Henderson KL, Coelho J, Hughes H, Mason EL, Gerver SM et al. Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill. 2023;28(1):2200942. doi: https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200942.
de Gier B, Marchal N, de Beer-Schuurman I, te Wierik M, Hooiveld M, de Melker HE et al. Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022. Euro Surveill. 2023;28(1):2200941. doi: https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200941.
World Health Organization (WHO). Increased incidence of scarlet fever and invasive Group A Streptococcus infection - multi-country. [Internet.] Geneva: WHO; 15 December 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON429.
Barnes M, Youngkin E, Zipprich J, Bilski K, Gregory CJ, Dominguez SR. Notes from the Field: increase in pediatric invasive group A Streptococcus infections — Colorado and Minnesota, October–December 2022. MMWR Morb Mortal Wkly Rep. 2023;72(10):265–7. doi: https://doi.org/10.15585/mmwr.mm7210a4.
Abo YN, Oliver J, McMinn A, Osowicki J, Baker C, Clark JE et al. Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges. Lancet Reg Health West Pac. 2023;41:100873. doi: https://doi.org/10.1016/j.lanwpc.2023.100873.
Victoria State Government Department of Health. Public Health and Wellbeing Regulations 2019. [Webpage.] Melbourne: Victoria State Government Department of Health; 26 February 2024. Available from: https://www.health.vic.gov.au/legislation/public-health-and-wellbeing-regulations-2019.
Australian Bureau of Statistics. Regional population by age and sex: reference period 2023. [Webpage.] Canberra; Australian Bureau of Statistics; 29 August 2024. Available from: https://www.abs.gov.au/statistics/people/population/regional-population-age-and-sex/2023.
R Core Team. R: A Language and Environment for Statistical Computing. [Application.] Vienna: R Foundation for Statistical Computing; 2021. Available from: https://www.R-project.org/.
King ME, Bensyl DM, Goodman RA, Rasmussen SA. The CDC Field Epidemiology Manual: Conducting a Field Investigation. [Webpage.] Atlanta: United States Government Department of Health and Human Resources, Centers for Disease Control and Prevention, Epidemic Intelligence Service; 13 December 2018. Available from: https://www.cdc.gov/eis/field-epi-manual/chapters/Field-Investigation.html.
Victoria State Government Department of Health. Public Health and Wellbeing Act 2008. [Webpage.] Melbourne: Victoria State Government Department of Health; 2 January 2025. Available from: https://www.health.vic.gov.au/legislation/public-health-and-wellbeing-act-2008.
Victoria State Government Department of Health. Streptococcal disease (Group A beta-haemolytic streptococcus). [Webpage.] Melbourne: Victoria State Government Department of Health; 26 February 2024. Available from: https://www.health.vic.gov.au/infectious-diseases/streptococcal-disease-group-a-beta-haemolytic-streptococcus.
Falck G, Kjellander J. Outbreak of group A streptococcal infection in a day-care center. Pediatr Infect Dis J. 1992;11(11):914–9. doi: https://doi.org/10.1097/00006454-199211110-00002.
Feeney KT, Dowse GK, Keil AD, Mackaay C, McLellan D. Epidemiological features and control of an outbreak of scarlet fever in a Perth primary school. Commun Dis Intell Q Rep. 2005;29(4):386–90.
Hoebe CJ, Wagenvoort JH, Schellekens JF. [An outbreak of scarlet fever, impetigo and pharyngitis caused by the same Streptococcus pyogenes type T4M4 in a primary school]. Ned Tijdschr Geneeskd. 2000;144(45):2148–52.
Lamden KH. An outbreak of scarlet fever in a primary school. Arch Dis Child. 2011;96(4):394–7. doi: https://doi.org/10.1136/adc.2010.189944.
Saad NJ, Muller N, Walter J, Murajda L. Scarlet fever outbreak in a primary and middle school in Germany: importance of case ascertainment and risk communication. Epidemiol Infect. 2020;148:e278. doi: https://doi.org/10.1017/S0950268820002642.
Oliver J, Wilmot M, Strachan J, St George S, Lane CR, Ballard SA et al. Recent trends in invasive group A Streptococcus disease in Victoria. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.8.
Lamagni T, McGregor C, Guy RL, Whitworth J, Efstratiou A. Seizing opportunities for prevention of group A streptococcal infection. Lancet Microbe. 2024;5(5):e415. doi: https://doi.org/10.1016/S2666-5247(23)00404-4.
Chalker V, Jironkin A, Coelho J, Al-Shahib A, Platt S, Kapatai G et al. Genome analysis following a national increase in scarlet fever in England 2014. BMC Genomics. 2017;18(1):224. doi: https://doi.org/10.1186/s12864-017-3603-z.
Watts V, Balasegaram S, Brown CS, Mathew S, Mearkle R, Ready D et al. Increased risk for invasive group A Streptococcus disease for household contacts of scarlet fever cases, England, 2011–2016. Emerg Infect Dis. 2019;25(3):529–37. doi: https://doi.org/10.3201/eid2503.181518.
Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335(8):547–54. doi: https://doi.org/10.1056/NEJM199608223350803.
Khan F, Bai Z, Kelly S, Skidmore B, Dickson C, Nunn A et al. Effectiveness and safety of antibiotic prophylaxis for persons exposed to cases of invasive group A streptococcal disease: a systematic review. Open Forum Infect Dis. 2022;9(8):ofac244. doi: https://doi.org/10.1093/ofid/ofac244.
Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics. 2000;105(5):E60. doi: https://doi.org/10.1542/peds.105.5.e60.
Aebi C, Ahmed A, Ramilo O. Bacterial complications of primary varicella in children. Clin Infect Dis. 1996;23(4):698–705. doi: https://doi.org/10.1093/clinids/23.4.698.
Scaber J, Saeed S, Ihekweazu C, Efstratiou A, McCarthy N, O’Moore E. Group A streptococcal infections during the seasonal influenza outbreak 2010/11 in South East England. Euro Surveill. 2011;16(5):19780. doi: https://doi.org/10.2807/ese.16.05.19780-en.
Jean C, Louie JK, Glaser CA, Harriman K, Hacker JK, Aranki F et al. Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza. Clin Infect Dis. 2010;50(10):e59–62. doi: https://doi.org/10.1086/652291.
Aebi T, Weisser M, Bucher E, Hirsch HH, Marsch S, Siegemund M. Co-infection of influenza B and streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect Dis. 2010;10(1):308. doi: https://doi.org/10.1186/1471-2334-10-308.
Cordery R, Purba AK, Begum L, Mills E, Mosavie M, Vieira A et al. Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK. Lancet Microbe. 2022;3(5):e366–75. doi: https://doi.org/10.1016/S2666-5247(21)00332-3.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
